SCHEMBL7871763

SCHEMBL7871763

NC[C@@H](N)CCCC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 6/20 0.65
ALDH1A1 P00352 2/20 0.53
LMNA P02545 4/20 0.50
GABRP O00591 3/20 0.50
GABRD O14764 3/20 0.50
GABRA1 P14867 3/20 0.50
GABRB1 P18505 3/20 0.50
GABRG2 P18507 3/20 0.50
GABRB3 P28472 3/20 0.50
GABRA5 P31644 3/20 0.50
GABRA3 P34903 3/20 0.50
GABRA2 P47869 3/20 0.50
GABRB2 P47870 3/20 0.50
GABRA4 P48169 3/20 0.50
GABRE P78334 3/20 0.50
GABRA6 Q16445 3/20 0.50
GABRG1 Q8N1C3 3/20 0.50
GABRG3 Q99928 3/20 0.50
GABRQ Q9UN88 3/20 0.50
THRB P10828 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4737817 1.00 ENPEP (0.65) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7873463 1.00 ENPEP (0.65) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7876092 0.93 ENPEP (0.67) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL8637959 0.93 ENPEP (0.67) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7864358 0.93 ENPEP (0.67) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7873477 0.91 ALDH1A1 (0.66) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7875995 0.91 ALDH1A1 (0.66) ENPEPALDH1A1LMNAGABRPGABRD
Butyric Acid SCHEMBL3971503 0.90 ALDH1A1 (0.59) ENPEPALDH1A1KMT2ATSHRHDAC3
Hydrochloric Acid SCHEMBL10789749 0.89 ALDH1A1 (0.63) ENPEPALDH1A1LMNAGABRPGABRD
SCHEMBL7823258 0.87 ENPEP (0.74) ENPEPALDH1A1LMNAGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316652-B1 MITOPLATIN METAL COMPLEXES THAT ARE CISPLATIN DERIVATIVES; ANTITUMOR, ANTICARCINOGENIC, ANTIDIABETIC AND ANTIARTHRITIC AGENTS STELIOU, KOSTA 2001-11-13 US disclosed